CT Liver-Spleen scan imaging showed tracer uptake in the mass posterior to the pancreas (suggesting splenule) but not in the mass within the tail of pancreas. He was referred to us for endoscopic ultrasonography (EUS) to further characterize the lesion. EUS revealed an oval hypoechoic mass in the tail of pancreas measuring 15 mm by 11 mm in maximal cross-sectional diameter, with well-defi ned margins and no invasion of adjacent structures. Th e remainder of the pancreas was well visualized, the pancreatic duct appeared normal, and there were no other abnormalities. A needle aspiration of the mass was performed. EUS characteristics and a preliminary cytology reading suggested a neuroendocrine tumor. Final pathology results on the needle aspiration specimen revealed a heterogeneous population of B-and T-lymphocytes without cytologic or immunohistochemical evidence of a neuroendocrine tumor or lymphoma. Despite this benign pathology, we were concerned that a lymphoproliferative disorder might have been missed by biopsy sampling error. Two months later, we performed a repeat EUS; fi ne needle biopsy with a pro-core needle was performed with several passes. Pathology again revealed a heterogeneous population of benign B-and T-lymphocytes (Figure 2) , indicating that the lesion identifi ed by MRI imaging and EUS was a lymph node embedded in the pancreas. Discussion: Solid lesions of the pancreas are oft en neoplastic. Th e most frequent benign causes of solid pancreatic masses include chronic pancreatitis, autoimmune pancreatitis, lipoma and splenule. Th ere is no defi nitive sign that can reliably identify intra-pancreatic lymph nodes on cross-sectional imaging or EUS. Hence, it should be considered in the diff erential of an isolated pancreatic mass, especially in an asymptomatic, healthy patient with otherwise normal imaging. Sulfur Colloid SPECT/CT Liver-Spleen scan can be helpful in these situations to rule out splenule. If staining for neuroendocrine tumor markers is unremarkable, then immunohistochemical staining to identify normal lymphoid tissue should be done to avoid potentially hazardous surgery for a harmless, benign condition.
Case:
A 62 year-old man with a history of a cholecystectomy presented with long-standing right upper quadrant pain. A computed tomography (CT) scan demonstrated a normal spleen with incidental small adjacent splenules and a 2.4 x 2.3 cm cystic lesion in the tail of the pancreas. Th e pancreatic cystic lesion (PCL) was not seen on a CT scan two years prior, while an interim CT-scan had revealed a size of 1.1 x 1.1 cm. Th e patient underwent an endoscopic ultrasound (EUS) that demonstrated a 2.5 x 2.2 cm anechoic thin walled cystic lesion within the pancreatic tail. During EUS, needle-based confocal endomicroscopy (nCLE) was performed (on study protocol [INDEX study: In vivo Needle based CLE and Ex vivo Diagnosis for PCLs]) with an AQ Flex-19 miniprobe (Cellvizio; Mauna Kea Technologies Inc, Suwanee, GA). Open sinuses and cellular cords with many red blood cells suggestive of splenic red pulp were observed within the epidermoid cyst with absence of patterns concerning for a malignant process. Following nCLE, the patient underwent an EUS fi ne needle aspiration of the cyst and cytology was nondiagnostic with an elevated CEA to 2663 ng/mL. Th e increase in size of the PCL in conjunction with an elevated CEA and were key determinants for the patient to undergo a laparoscopic distal pancreatectomy and splenectomy. Per INDEX study protocol, ex vivo confocal laser endomicroscopy was performed with a Gastrofl ex ultrahigh defi nition probe (Cellvizio) in the post-surgical setting to validate in vivo EUS-nCLE fi ndings. Site-specifi c biopsies were obtained from foci where ex vivo CLE was performed and showed a benign intrapancreatic epidermoid cyst with mural ectopic splenic tissue, compatible with an epidermoid cyst of accessory spleen. Discussion: As this case depicts, IPAS can be diffi cult to distinguish by cross sectional imaging and is oft en evaluated for neoplastic potential. Th is is the fi rst report of in vivo EUS-nCLE in a patient with an epidermoid cyst within an IPAS. Th e in vivo nCLE fi ndings were corroborated by ex vivo CLE and pathologic correlation. EUS-nCLE fi ndings can be potentially complementary and combined with novel cyst fl uid molecular markers. Indeed, a collective strategy using EUS-nCLE and cyst fl uid molecular markers may prove to be superior for accurate diagnosis and risk stratifi cation of PCLs. Th e ultimate goal is to guide complex decisions of surgical intervention, ongoing imaging surveillance, or no further follow-up. Background: Bouveret syndrome is caused by an impacted gallstone leading to ischemic necrosis and formation of fi stulous tract through which the stone passes into small bowel (SB). Stones < 2.5 cm usually pass through upper SB before impaction in terminal ileum (50-75%), or jejunum (20-40%), while larger (>2.5cm) ones become impacted in pylorus/proximal duodenum causing gastric outlet obstruction (GOO). Th e classic "Rigler's triad" (GOO, pneumobilia and ectopic gallstone) is identifi ed on abdominal imaging. Endoscopic interventions are successful in only 9% of cases, and rest requiring surgical management. Case: A 37-year-old lady presented with epigastric pain, persistent vomiting and fever. Laboratory workup showed mild leukocytosis (12.6x103) and CT revealed a complex mass in gallbladder fossa/second duodenum raising concern for intraluminal neoplasm versus an abscess, causing GOO. EGD revealed it to be a large gallstone, completely obstructing the duodenum and bile duct (pseudo-Mirizzi's syndrome). All endoscopic eff orts to dislodge it with roth net, talon, snares, raptor/alligator forceps failed. MRCP disclosed signifi cant air in the gallbladder lumen with a linear T2 hyperintense tract from gallbladder fossa to duodenum, representing a cholecystoduodenal fi stula. Given her surgical comorbidities including morbid obesity, diabetes and ongoing infection, she was deemed high surgical risk. Repeat endoscopic management was hence attempted with laser lithotripsy, which partially fragmented, but failed to dislodge the stone. Multidisciplinary approach was adopted, and a biliary stent was placed during ERCP, for decompression, while sepsis was managed with antibiotics and for intraoperative ease of common bile duct (CBD) identifi cation. Aft er stabilization, patient underwent exploratory laparotomy, which showed a large stone impacted in the fi stulous tract. Identifi cation of CBD was easy with palpation of the previously placed stent, thus eliminating inadvertent dissection and injuries, while fi stulous tracts were repaired. Patient showed remarkable clinical improvement. Stent was removed 2 months later. Discussion:Multi-disciplinary approach is oft en needed for safe and eff ective management of this complex condition. Placement of biliary stent is a useful technique to achieve biliary decompression and prevent further passage of stones. It also helps the surgeons as a landmark, aiding defi nitive surgical management.
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